News coverage about R1 RCM (NYSE:RCM) has trended somewhat positive this week, Accern Sentiment reports. The research group rates the sentiment of news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. R1 RCM earned a news impact score of 0.17 on Accern’s scale. Accern also gave media coverage about the company an impact score of 47.3373523826879 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Separately, Zacks Investment Research raised shares of R1 RCM from a “hold” rating to a “buy” rating and set a $4.00 price target on the stock in a research note on Thursday, July 6th.

R1 RCM (NYSE RCM) traded up 6.17% during midday trading on Monday, hitting $3.27. 332,143 shares of the company’s stock traded hands. The company has a 50 day moving average of $4.56 and a 200-day moving average of $3.87. R1 RCM has a 52 week low of $1.61 and a 52 week high of $4.37.

R1 RCM (NYSE:RCM) last issued its quarterly earnings results on Wednesday, August 2nd. The company reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by $0.07. The business had revenue of $99.40 million for the quarter, compared to analyst estimates of $91.95 million. R1 RCM had a negative return on equity of 128.00% and a negative net margin of 9.55%. On average, analysts anticipate that R1 RCM will post ($0.04) EPS for the current year.

TRADEMARK VIOLATION WARNING: “R1 RCM (NYSE:RCM) Receives Daily Coverage Optimism Rating of 0.17” was published by Watch List News and is the property of of Watch List News. If you are reading this piece on another website, it was illegally stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece can be accessed at https://www.watchlistnews.com/r1-rcm-nysercm-receives-daily-coverage-optimism-rating-of-0-17/1487863.html.

About R1 RCM

R1 RCM Inc, formerly Accretive Health, Inc, is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers.

Receive News & Ratings for R1 RCM Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.